ChromoCure, Inc. (KKUR)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 27, 2025

ChromoCure Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2009 FY 2008 FY 2005 FY 2004 FY 2003
Period Ending
Dec '09 Dec '08 Dec '05 Dec '04 Dec '03
Net Income
-0.15-0.06-0.15-0.34-0.26
Depreciation & Amortization
00---
Stock-Based Compensation
----0.13
Change in Inventory
0.32----
Change in Accounts Payable
---0.29-00.05
Operating Cash Flow
0.17-0.05-0.43-0.34-0.08
Capital Expenditures
-0.15----
Sale (Purchase) of Intangibles
-1.33----
Investing Cash Flow
-1.48----
Long-Term Debt Issued
0.28-0.340.160.05
Net Debt Issued (Repaid)
0.28-0.340.160.05
Issuance of Common Stock
0.670.060.090.370.02
Other Financing Activities
0.46---0.17-
Financing Cash Flow
1.420.060.420.360.07
Net Cash Flow
0.110-0.010.02-0.01
Free Cash Flow
0.02-0.05-0.43-0.34-0.08
Free Cash Flow Margin
---182.66%-824.36%-
Free Cash Flow Per Share
---0.74-1.28-0.34
Levered Free Cash Flow
---0.32-0.23-
Unlevered Free Cash Flow
---0.32-0.23-
Change in Net Working Capital
--0.230.02-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.